RecallDepth
Class II Ongoing

Lisdexamfetamine Dimesylate Capsules, 20 mg, CII, 100-count bottle, Rx only, Manufactured by: OHM Laboratories, New Brunswick, NJ 08901, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 57664-047-88.

This recall is currently active, issued November 5, 2025. It was issued by Sun Pharmaceutical Industries Inc.

Company
Sun Pharmaceutical Industries Inc
Recall Initiated
October 28, 2025
Posted
November 5, 2025
Recall Number
D-0145-2026
Voluntary / Mandated
Voluntary: Firm initiated
Firm Location
Princeton, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Failed Dissolution Specifications: An out of specification results observed in dissolution test during analysis at 12-month long term stability station (25¿C, 60%RH) for Lisdexamfetamine dimesylate capsules.

Distribution

U.S Nationwide.

Lot / Code Info

Lot #: AD42469, Expiry: 2/28/2026; AD48707, Expiry:4/30/2026.

More recalls by Sun Pharmaceutical Industries Inc

View all recalls by this company →

Other recent Class II Drug recalls